June 29, 2022

AlloSource Launches AlloFuse Micro Fiber Allograft

AlloSource Launches AlloFuse Micro Fiber Allograft
AlloFuse Micro Fibers are the latest addition to the AlloFuse line of Fibers and Fiber Boat products, expanding the company's portfolio.
June 21, 2022

Bioventus Amends CartiHeal Acquisition Structure

Bioventus Amends CartiHeal Acquisition Structure
The amended agreement reduces the closing payment to $50 million (plus $50 million deposited into escrow last year) from the original $315 million.
June 13, 2022

Graftys Granted Patent for CPC Mixed with Blood

Graftys Granted Patent for CPC Mixed with Blood
Based on blood clotting processing, this new macroporous calcium phosphate cement is designed to stimulate bone regeneration.
June 10, 2022

Lipogems To Launch Study to Treat Knee Osteoarthritis

Lipogems To Launch Study to Treat Knee Osteoarthritis
Lipogems will conduct an IDE study for treatment of knee osteoarthritis compared to corticosteroids for a period of 12 months.
May 31, 2022

Kuros MagnetOs: First Trial Results

Kuros MagnetOs: First Trial Results
Kuros Biosciences announces favorable preliminary results for MagnetOs as standalone alternative to autograft in its first randomized controlled trial.

M&A | Partnerships

June 21, 2022

Bioventus Amends CartiHeal Acquisition Structure

Bioventus Amends CartiHeal Acquisition Structure
The amended agreement reduces the closing payment to $50 million (plus $50 million deposited into escrow last year) from the original $315 million.
April 25, 2022

ORHub Acquires PUR Biologics

ORHub Acquires PUR Biologics
ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis.

Products

June 29, 2022

AlloSource Launches AlloFuse Micro Fiber Allograft

AlloSource Launches AlloFuse Micro Fiber Allograft
AlloFuse Micro Fibers are the latest addition to the AlloFuse line of Fibers and Fiber Boat products, expanding the company's portfolio.
June 13, 2022

Graftys Granted Patent for CPC Mixed with Blood

Graftys Granted Patent for CPC Mixed with Blood
Based on blood clotting processing, this new macroporous calcium phosphate cement is designed to stimulate bone regeneration.

Regulatory